Hydrochlorothiazide Tablet
Product Images NDC 51655-272

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 51655-272). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (1e6dbc0e 5e51 4b2b 9320 A3715deee20b 01)

Image (1e6dbc0e 5e51 4b2b 9320 A3715deee20b 01)
Chemical structure diagram of hydrochlorothiazide showing its molecular arrangement including sulfur, nitrogen, oxygen, chlorine, and other atoms.*
FDA Label Image

Image (1e6dbc0e 5e51 4b2b 9320 A3715deee20b 02)

FDA Label Image

Label (51655 272 26 Master Bottle Label Approval Rev A 07 20)

Label (51655 272 26 Master Bottle Label Approval   Rev A 07 20)
HYDROCHLOROTHIAZIDE 25 mg oral tablets packaging label from Northwind Health Company, LLC. The label indicates 90 tablets per container, prescription use only, with storage instructions and safety warnings. The product NDC is 51655-272-26.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.